Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02839915
Recruitment Status : Not yet recruiting
First Posted : July 21, 2016
Last Update Posted : August 20, 2019
Sponsor:
Collaborators:
Phoenix Children's Hospital
Harvard University
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by (Responsible Party):
Lawrence Scahill, MSN, PhD, Emory University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : January 1, 2022
Estimated Study Completion Date : January 1, 2023